Cargando…
Nuclear Envelope Alterations in Myotonic Dystrophy Type 1 Patient-Derived Fibroblasts
Myotonic dystrophy type 1 (DM1) is a hereditary and multisystemic disease characterized by myotonia, progressive distal muscle weakness and atrophy. The molecular mechanisms underlying this disease are still poorly characterized, although there are some hypotheses that envisage to explain the multis...
Autores principales: | Viegas, Diana, Pereira, Cátia D., Martins, Filipa, Mateus, Tiago, da Cruz e Silva, Odete A. B., Herdeiro, Maria Teresa, Rebelo, Sandra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8745202/ https://www.ncbi.nlm.nih.gov/pubmed/35008948 http://dx.doi.org/10.3390/ijms23010522 |
Ejemplares similares
-
Metabolic Alterations in Myotonic Dystrophy Type 1 and Their Correlation with Lipin
por: Mateus, Tiago, et al.
Publicado: (2021) -
Fourier-Transform Infrared Spectroscopy as a Discriminatory Tool for Myotonic Dystrophy Type 1 Metabolism: A Pilot Study
por: Mateus, Tiago, et al.
Publicado: (2021) -
Nuclear envelope dysfunction and its contribution to the aging process
por: Martins, Filipa, et al.
Publicado: (2020) -
Protein Phosphorylation Alterations in Myotonic Dystrophy Type 1: A Systematic Review
por: Costa, Adriana, et al.
Publicado: (2023) -
Nuclear Envelope Transmembrane Proteins in Myotonic Dystrophy Type 1
por: Hintze, Stefan, et al.
Publicado: (2018)